vs
UiPath, Inc.（PATH）与West Pharmaceutical Services（WST）财务数据对比。点击上方公司名可切换其他公司
West Pharmaceutical Services的季度营收约是UiPath, Inc.的2.0倍（$805.0M vs $411.1M），UiPath, Inc.净利率更高（48.4% vs 16.4%，领先32.0%），UiPath, Inc.同比增速更快（15.9% vs 7.5%），West Pharmaceutical Services自由现金流更多（$175.0M vs $25.1M），过去两年West Pharmaceutical Services的营收复合增速更高（7.6% vs 0.7%）
UiPath是一家全球化软件企业，专注于开发人工智能、智能自动化及流程编排类软件，其产品支持用户搭建与调度AI代理，实现复杂业务流程、工作流的自动化运行，助力各行业客户提升运营效率、降低人力成本。
美国West Pharmaceutical Services是注射用药品包装及给药系统的设计和制造商，1923年成立，总部位于宾夕法尼亚州埃克斯顿。成立初期主营注射类药物包装用橡胶组件，曾为青霉素和胰岛素生产商提供符合无菌要求的配套产品。
PATH vs WST — 直观对比
营收规模更大
WST
是对方的2.0倍
$411.1M
营收增速更快
PATH
高出8.4%
7.5%
净利率更高
PATH
高出32.0%
16.4%
自由现金流更多
WST
多$149.9M
$25.1M
两年增速更快
WST
近两年复合增速
0.7%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $411.1M | $805.0M |
| 净利润 | $198.8M | $132.1M |
| 毛利率 | 83.3% | 37.8% |
| 营业利润率 | 3.2% | 19.5% |
| 净利率 | 48.4% | 16.4% |
| 营收同比 | 15.9% | 7.5% |
| 净利润同比 | 1966.2% | 1.5% |
| 每股收益（稀释后） | $0.37 | $1.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PATHWST
| Q4 25 | $411.1M | $805.0M | ||
| Q3 25 | $361.7M | $804.6M | ||
| Q2 25 | $356.6M | $766.5M | ||
| Q1 25 | $423.6M | $698.0M | ||
| Q4 24 | $354.7M | $748.8M | ||
| Q3 24 | $316.3M | $746.9M | ||
| Q2 24 | $335.1M | $702.1M | ||
| Q1 24 | $405.3M | $695.4M |
净利润PATHWST
| Q4 25 | $198.8M | $132.1M | ||
| Q3 25 | $1.6M | $140.0M | ||
| Q2 25 | $-22.6M | $131.8M | ||
| Q1 25 | $51.8M | $89.8M | ||
| Q4 24 | $-10.7M | $130.1M | ||
| Q3 24 | $-86.1M | $136.0M | ||
| Q2 24 | $-28.7M | $111.3M | ||
| Q1 24 | $33.9M | $115.3M |
毛利率PATHWST
| Q4 25 | 83.3% | 37.8% | ||
| Q3 25 | 82.2% | 36.6% | ||
| Q2 25 | 82.1% | 35.7% | ||
| Q1 25 | 84.8% | 33.2% | ||
| Q4 24 | 82.0% | 36.5% | ||
| Q3 24 | 80.0% | 35.4% | ||
| Q2 24 | 83.5% | 32.8% | ||
| Q1 24 | 86.8% | 33.1% |
营业利润率PATHWST
| Q4 25 | 3.2% | 19.5% | ||
| Q3 25 | -5.6% | 20.8% | ||
| Q2 25 | -4.6% | 20.1% | ||
| Q1 25 | 7.9% | 15.3% | ||
| Q4 24 | -12.2% | 21.3% | ||
| Q3 24 | -32.7% | 21.6% | ||
| Q2 24 | -14.8% | 18.0% | ||
| Q1 24 | 3.7% | 17.7% |
净利率PATHWST
| Q4 25 | 48.4% | 16.4% | ||
| Q3 25 | 0.4% | 17.4% | ||
| Q2 25 | -6.3% | 17.2% | ||
| Q1 25 | 12.2% | 12.9% | ||
| Q4 24 | -3.0% | 17.4% | ||
| Q3 24 | -27.2% | 18.2% | ||
| Q2 24 | -8.6% | 15.9% | ||
| Q1 24 | 8.4% | 16.6% |
每股收益（稀释后）PATHWST
| Q4 25 | $0.37 | $1.82 | ||
| Q3 25 | $0.00 | $1.92 | ||
| Q2 25 | $-0.04 | $1.82 | ||
| Q1 25 | $0.09 | $1.23 | ||
| Q4 24 | $-0.02 | $1.78 | ||
| Q3 24 | $-0.15 | $1.85 | ||
| Q2 24 | $-0.05 | $1.51 | ||
| Q1 24 | $0.07 | $1.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $791.3M |
| 总债务越低越好 | — | $202.8M |
| 股东权益账面价值 | $1.9B | $3.2B |
| 总资产 | $2.9B | $4.3B |
| 负债/权益比越低杠杆越低 | — | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资PATHWST
| Q4 25 | $1.4B | $791.3M | ||
| Q3 25 | $1.4B | $628.5M | ||
| Q2 25 | $1.6B | $509.7M | ||
| Q1 25 | $1.6B | $404.2M | ||
| Q4 24 | $1.6B | $484.6M | ||
| Q3 24 | $1.7B | $490.9M | ||
| Q2 24 | $1.9B | $446.2M | ||
| Q1 24 | $1.9B | $601.8M |
总债务PATHWST
| Q4 25 | — | $202.8M | ||
| Q3 25 | — | $202.7M | ||
| Q2 25 | — | $202.6M | ||
| Q1 25 | — | $202.6M | ||
| Q4 24 | — | $202.6M | ||
| Q3 24 | — | $202.6M | ||
| Q2 24 | — | $205.8M | ||
| Q1 24 | — | $206.2M |
股东权益PATHWST
| Q4 25 | $1.9B | $3.2B | ||
| Q3 25 | $1.7B | $3.1B | ||
| Q2 25 | $1.7B | $2.9B | ||
| Q1 25 | $1.8B | $2.7B | ||
| Q4 24 | $1.7B | $2.7B | ||
| Q3 24 | $1.8B | $2.8B | ||
| Q2 24 | $2.0B | $2.6B | ||
| Q1 24 | $2.0B | $2.7B |
总资产PATHWST
| Q4 25 | $2.9B | $4.3B | ||
| Q3 25 | $2.6B | $4.1B | ||
| Q2 25 | $2.6B | $4.0B | ||
| Q1 25 | $2.9B | $3.6B | ||
| Q4 24 | $2.7B | $3.6B | ||
| Q3 24 | $2.7B | $3.7B | ||
| Q2 24 | $2.8B | $3.5B | ||
| Q1 24 | $3.0B | $3.6B |
负债/权益比PATHWST
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.08× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | 0.07× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 0.08× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.3M | $251.1M |
| 自由现金流经营现金流 - 资本支出 | $25.1M | $175.0M |
| 自由现金流率自由现金流/营收 | 6.1% | 21.7% |
| 资本支出强度资本支出/营收 | 0.8% | 9.5% |
| 现金转化率经营现金流/净利润 | 0.14× | 1.90× |
| 过去12个月自由现金流最近4个季度 | — | $468.9M |
8季度趋势，按日历期对齐
经营现金流PATHWST
| Q4 25 | $28.3M | $251.1M | ||
| Q3 25 | $41.6M | $197.2M | ||
| Q2 25 | $119.0M | $177.1M | ||
| Q1 25 | $146.1M | $129.4M | ||
| Q4 24 | $28.1M | $190.1M | ||
| Q3 24 | $46.4M | $180.1M | ||
| Q2 24 | $100.0M | $165.0M | ||
| Q1 24 | $145.6M | $118.2M |
自由现金流PATHWST
| Q4 25 | $25.1M | $175.0M | ||
| Q3 25 | — | $133.9M | ||
| Q2 25 | $106.2M | $101.9M | ||
| Q1 25 | $138.7M | $58.1M | ||
| Q4 24 | $23.2M | $85.2M | ||
| Q3 24 | $45.0M | $98.8M | ||
| Q2 24 | $98.8M | $64.8M | ||
| Q1 24 | $141.8M | $27.6M |
自由现金流率PATHWST
| Q4 25 | 6.1% | 21.7% | ||
| Q3 25 | — | 16.6% | ||
| Q2 25 | 29.8% | 13.3% | ||
| Q1 25 | 32.7% | 8.3% | ||
| Q4 24 | 6.5% | 11.4% | ||
| Q3 24 | 14.2% | 13.2% | ||
| Q2 24 | 29.5% | 9.2% | ||
| Q1 24 | 35.0% | 4.0% |
资本支出强度PATHWST
| Q4 25 | 0.8% | 9.5% | ||
| Q3 25 | 0.0% | 7.9% | ||
| Q2 25 | 3.6% | 9.8% | ||
| Q1 25 | 1.7% | 10.2% | ||
| Q4 24 | 1.4% | 14.0% | ||
| Q3 24 | 0.4% | 10.9% | ||
| Q2 24 | 0.4% | 14.3% | ||
| Q1 24 | 0.9% | 13.0% |
现金转化率PATHWST
| Q4 25 | 0.14× | 1.90× | ||
| Q3 25 | 26.25× | 1.41× | ||
| Q2 25 | — | 1.34× | ||
| Q1 25 | 2.82× | 1.44× | ||
| Q4 24 | — | 1.46× | ||
| Q3 24 | — | 1.32× | ||
| Q2 24 | — | 1.48× | ||
| Q1 24 | 4.29× | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |
WST
| Proprietary Products | $661.8M | 82% |
| Contract Manufactured Products | $143.2M | 18% |
| Affiliated Entity | $3.3M | 0% |
